Ironwood Financial’s aTyr Pharma ATYR Stock Holding History

Ironwood Financial’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50	Closed	–	–	569
2021 Q3	$0	Hold	50	–	–	﹤0.01%	606
2021 Q2	$0	Sell	50 -6	-11%	-$26	﹤0.01%	592
2021 Q1	$0	Buy	+56	New	+$263	﹤0.01%	576

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ironwood Financial's ATYR Position: Q4 2021 in Review

Ironwood Financial sold out of aTyr Pharma (ATYR) in Q4 2021, closing a stake of 50 shares.

Ironwood Financial first reported a position in ATYR in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 47 funds tracked by Wall St. Rank hold ATYR as of Q4 2021.

Ironwood Financial reported no remaining aTyr Pharma position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 50 aTyr Pharma shares in Q4 2021.
Ironwood Financial first reported a position in aTyr Pharma in Q1 2021 and held it in 3 quarters.
Ironwood Financial's aTyr Pharma position peaked at $0 in Q3 2021.
47 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.